BPI 004
Alternative Names: BPI-004Latest Information Update: 28 Sep 2023
Price :
$50 *
At a glance
- Originator BeyondSpring Pharmaceuticals
- Class Antineoplastics; Immunotherapies; Small molecules
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer